Please login to the form below

Not currently logged in
Email:
Password:

Eisai’s Bose to join Boehringer

He becomes head of global marketing for oncology

boehringer-uday-boseBoehringer Ingelheim has named Eisai's Uday Bose as head of global marketing for its oncology business.

Taking up the role on August 1, Bose will lead marketing efforts for Boehringer's fledgling activities in cancer, which has become an increasingly important area for the company since the launch of its first oncology product Giotrif (afatinib) last year.

Since then Boehringer has also filed its second cancer product nintedanib for approval in lung cancer.

Bose's responsibilities include the long-term marketing plan for the cancer portfolio, as well as the development of global strategies for Boehringer's cancer products and guiding the launch and marketing of individual drugs.

Bose is currently head of the oncology business unit for the EMEA region at Eisai – a position he has held since 2010. His past experience include senior marketing roles at GSK's oncology business and product manager positions at Sanofi.

14th July 2014

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics